Comparative Pharmacokinetic Study of Lidocaine Patch 1.8% (ZTlido™) and Lidocaine Patch 5% (Lidoderm®) in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

September 28, 2016

Primary Completion Date

October 27, 2016

Study Completion Date

October 27, 2016

Conditions
Healthy
Interventions
DRUG

Lidocaine topical system 1.8%

DRUG

Lidocaine patch 5%

All Listed Sponsors
lead

Scilex Pharmaceuticals, Inc.

INDUSTRY

NCT04149938 - Comparative Pharmacokinetic Study of Lidocaine Patch 1.8% (ZTlido™) and Lidocaine Patch 5% (Lidoderm®) in Healthy Subjects | Biotech Hunter | Biotech Hunter